Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 202

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

A new HMG‐CoA reductase inhibitor, rosuvastatin, exerts anti‐inflammatory effects on the microvascular endothelium: the role of mevalonic acid

Open access
Stalker, Timothy J, Lefer, Allan M, Scalia, Rosario · 2001 · British Journal of Pharmacology

Abstract

Recent studies have reported that hydroxymethylglutaryl coenzyme A (HMG‐CoA) reductase inhibitors have vasculoprotective effects independent of their lipid‐lowering properties, including anti‐inflammatory actions. We used intravital microscopy of the rat mesenteric microvasculature to examine the effects of rosuvastatin, a new HMG‐CoA reductase inhibitor, on leukocyte‐endothelium interactions induced by thrombin. Intraperitoneal administration of 0.5 and 1.25 mg kg−1 rosuvastatin 18 h prior to the study, significantly and dose‐dependently attenuated leukocyte rolling, adherence, and transmigration in the rat mesenteric microvasculature superfused with 0.5 u ml‐1 thrombin. This protective effect of rosuvastatin was reversed by intraperitoneal injection of 25 mg kg−1 mevalonic acid 18 h before the study. Immunohistochemical detection of the endothelial cell adhesion molecule P‐selectin showed a 70% decrease in endothelial cell surface expression of P‐selectin in thrombin‐stimulated rats given 1.25 mg kg−1 rosuvastatin. In addition, rosuvastatin enhanced release of nitric oxide (NO) from the vascular endothelium as measured directly in rat aortic segments. Moreover, rosuvastatin failed to attenuate leukocyte‐endothelium interactions in peri‐intestinal venules of eNOS−/− mice. These data indicate that rosuvastatin exerts important anti‐inflammatory effects via inhibition of endothelial cell adhesion molecule expression, and that this protective action of rosuvastatin requires release of nitric oxide by the vascular endothelium. These data also demonstrate that the mechanism of the non‐lipid lowering actions of HMG‐CoA reductase inhibitors in vivo may be due to reduced formation or availability of mevalonic acid within endothelial cells. British Journal of Pharmacology (2001) 133, 406–412; doi:10.1038/sj.bjp.0704070

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0704070

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

Metadata

Authors
Stalker, T. J., Lefer, A. M., & Scalia, R.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2001-06
Volume
133
Issue
3
Pages
406-412
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2111419779
Cited by
202
References
3
FWCI
5.32
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.